Staphylococcal Infections Among Injection Drug Users Frederick L. Altice, M.D. Professor of Medicine Yale University School of Medicine.

Slides:



Advertisements
Similar presentations
Hospital-acquired and community-acquired MRSA in hospitals
Advertisements

NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Trends in Invasive Infection with MRSA
MRSA Community Acquired Methicillin Resistant Staphylococcus Aureus
A Comparative Study of Methicillin Resistant Staphylococcus aureus Nasal Carriage Rates Between Veterinarians and Veterinary Technicians Diane Hartman,
MRSA: Epidemiology & Treatment. MRSA: Epidemiology & Treatment: Points of this Talk - MRSA is primarily healthcare-associated - Community-acquired MRSA.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Invasive Group A Strep Infections Associated With Bath Salts Injection Patty Carson, BA, SM (ASCP) 1,2, Sara Robinson, MPH 1, Stephen Sears, MD, MPH 1.
Role of MRSA Swabs for De-escalation of Antibiotics in HCAP
CPC #2: Fever, cough, dyspnea, and change in mental status Barbara J. Crain, M.D., Ph.D. October 7, 2008.
Is it a spider bite or an infection? Brian M. Bourgeois, M.D., F.A.C.S. Westbank Industrial Medicine.
MRSA.
Methicillin Resistant Staphylococcus aureus (MRSA) in the Community: Epidemiology and Management Rachel Gorwitz, MD, MPH Division of Healthcare Quality.
Streptococcus pneumoniae Chapter 23. Streptococcus pneumoniae S. pneumoniae was isolated independently by Pasteur and Steinberg more than 100 years ago.
The War Against MRSA By Cynthia Zips, M, SM(ASCP), CIC October 25, 2013 MPH 500- Fundamentals of Public Health – Section 01- Fall A 2013 Instructor: Madeline.
1 Skilled Nursing, Inc. Staffing & Search MRSA Methicillin Resistant Staph Aureus HA MRSA and CA MRSA Causes SSTI’s, sepsis, necrotizing fascitis and fatality.
MRSA Methicillin Resistant Staphylococcus Aureus
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
MRSA Barbara Kilian, MD St.Luke’s Roosevelt Academic Associate Program Fall 2005.
The Ugly face of MRSA (Methicillin Resistant Staphylococcus aureus) MRSA is a staph aureus infection that has become resistant to the class of antibiotics,
Outpatient management of skin and soft tissue infections, specifically for community-associated MRSA Patient presents with signs/ symptoms of skin infection:
Surprising Victories Against Old Foes: New Hope for Prevention and Control of Healthcare- Associated MRSA Infections John A. Jernigan, MD, MS Division.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
Epidemiology and Control of Methicillin-Resistant Staphylococcus aureus in hospitals Maria Kapi,MD Registrar of Medical Microbiology Laiko General Hospital.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
A SECOND LOOK AT HOW TO COMBAT THIS THREAT JOHN WOODCOX RN CRRN.
MRSA PREPARED BY SARA ABUHIMED. Methicillin-resistant Staphylococcus Aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These.
©2008, Promega Corporation. All rights reserved. Emerging Pathogens Community-Associated Methicillin- Resistant Staphylococcus aureus.
Community- Associated MRSA Maha Assi, MD, MPH. MRSA Hits the Media October 16, 2007 October 16, 2007 Lead story on MRSA Lead story on MRSA “superbug killing.
Methicillin-Resistant Staphylococcus aureus (MRSA)
Big Bad Bugs in the Dialysis Unit Douglas Shemin, MD Kidney Diseases and Hypertension Division, Rhode Island Hospital.
Emerging and Re-emerging Diseases. Which killed more people: WWI ( ) or the Influenza Epidemic of 1918? World War I (1914 – 1918) death toll:
MRSA (Methicillin Resistant Staph. aureus) Geog 380.
Navpreet Sahsi.  Major pathogen of skin and soft tissue  Major nosocomial flora  Penicillin resistance in 1940’s  Methicillin resistance in 1960’s.
Staphylococcal Bacteremia and Endocarditis: Epidemiological Considerations March 6, 2006 John Edwards, Jr., M.D Professor of Medicine UCLA School of Medicine.
COMMUNITY ACQUIRED MRSA Pisespong Patamasucon, M.D. Pediatric Infectious Diseases UNSOM - Las Vegas.
The Super Bug? Alexander L. Brzezny, MD, MPH Health Officer Grant County Health District September 4 th, 2007.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
Community-acquired methicillin-resistant Staph. aureus (CA-MRSA): Amarillo experience Infectious Disease Epidemiology Work Group Texas Department of State.
Evidence-based Medicine. Case Presentation 27 yo AA male presents to clinic with 3 days of pain and swelling in right leg First noted several spider bites.
Module 2 - Epidemiology of Tuberculosis
Kow-Tong Chen, M.D., Ph.D., Hsiao-Ling Chang, Ph.D., Chu-Tzu Chen, M.P.H., and Ying-An Chen, M.P.H. Volume 23, Number 3, 2009 AIDS PATIENT CARE and STDs.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Understanding Methicillin-Resistant Staphylococcus aureus
Cheryl Meddles-Torres, DNP, RN, FNP-C Shuang Hu
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
Staphylococcus aureus Skin Infections
Lesson Overview Lesson Overview Diseases Caused by Bacteria and Viruses Lesson Overview 20.3 Diseases Caused by Bacteria and Viruses.
Methicillin Resistant Staphylococcus Aureus
Methicillin resistant Staphylococcus aureus. There are 2 types of MRSA: Community-acquired MRSA (CA-MRSA) This is passed throughout a community. You hear.
Abscess Management in a Post CA-MRSA era Erin Marra MD Simran Vahali MD 2016.
NPS Intravenous Use in the UK: Current Situation and Experiences Catherine Crawford, UK Focal Point.
Staph Infections. What is staph? Staphylococcus aureus, often referred to simply as “staph,” are bacteria commonly carried on the skin or in the nose.
1 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital DIABETES Care; Aug 2006; 29,8 : FM R1 임혜원.
Carriage Rates of Methicillin-Resistant Staphylococcus aureus (MRSA) Among College Students Ryan Kitzinger, Leigh Nelson, Chad Sethman, Ph.D. ABSTRACT.
MRSA Regina Livshits RN MSN NYU Langone Medical Center
Antibiotic-resistant Bacteria
Community-Associated MRSA Infections
PRESURE ULCER Pressure ulcers cause pain, decrease quality of life, and lead to significant morbidity and prolonged hospital stays, in part due to complicating.
Antibiotic Resistance
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Diseases caused by Staph. aureus
Clinical Challenges Community Acquired Methicillin Resistant Staph. Aureus Infections Jose R. Jimenez M.D. Eglin AFB, Florida.
Infection Control in ANesthesia
The challenges of multi-drug-resistance in hepatology
MRSA=Methicillin resistant Staphylococcus aureus
Presenter: Zipporah Machuki
Presentation transcript:

Staphylococcal Infections Among Injection Drug Users Frederick L. Altice, M.D. Professor of Medicine Yale University School of Medicine

Background ~13 million IDUs estimated worldwide 1 Skin and soft tissue infections are the leading cause for ER visits and hospitalizations for IDUs (S aureus & S pyogenes most common pathogens) 2 S aureus nasal carriage occurs in ~20% of people and associated with development of community- and nosocomial-acquired S aureus infections 3,4 IDUs have a higher rate of S aureus colonization than the general population 3,5 S aureus nasal carriage has been associated with  development of subsequent infections in IDUs 5 1. UNODC, 2004; 2. Palepu, CMAJ 2001; 3. Kluytmans, Clin Micro Rev 1997; 4. von Eiff, NEJM 2001; 5. Basetti, Infection 2004

S Aureus Expresses Many Potential Virulence Factors Surface proteins that promote colonization of host tissues Factors that probably inhibit phagocytosis (capsule, immunoglobulin binding protein A) Toxins that damage host tissues and cause disease symptoms Coagulase-negative staphylococci are normally less virulent and express fewer virulence factors – S epidermidis readily colonizes implanted devices

Skin and Soft Tissue Infections (SSTIs) Among IDUs Include local (cellulitis & abscesses) and necrotizing (complicated abscesses, necrotizing fasciitis, pyomyositis, myonecrosis) SSTIs Most common organisms are S aureus > S pyogenes > polymicrobial infections Related to local tissue trauma, direct effect of drugs, tissue ischemia and inoculation of bacteria – Increased risks: “skin popping”, use of non-sterile needles, “speedballs”, “booting”, licking the needle – Decreased risks: use of alcohol preparation of skin – Unclear association: HIV and immunosuppression Ebright, ID Clin NA, 2002

Skin and Soft Tissue Infections

Invasive Infections Among IDUs Most common cause is S aureus >> Strep >>>> GNRs Most commonly include bacteremia from local source (lungs, SSTIs), endocarditis and osteomyelitis Endocarditis more likely to be Right-Sided among IDUs than among non-IDUs Duration of antibiotics is prolonged though some evidence of shorter duration for right- sided infections

Invasive Infections

Emergence of MRSA Hospital-acquired MRSA (h-MRSA) – Plasmid-mediated – Not associated with toxin production – Associated with recent hospitalization and use of antibiotics – Highly resistant to most oral antibiotics, except linezolid Community-acquired MRSA (c-MRSA) – Chromosomally-mediated – Associated with toxin production (Panton-Valentine leukocidin) – Person-to-person transmission and not associated with traditional risk factors [IDUs, sexual contact and crowding … athletes, prisoners, homeless shelters, day care centers) – Sensitive to many oral antibiotics (TMP/SMZ, tetracycline, etc.)

Surveillance of S aureus and MRSA in the United States Colonization 1 – S aureus: 89.4 million (32%) and MRSA: 2.3 million (0.8%) Hospitalization – ICUs (1974 – 2%; 1995 – 22%; 2004 – 64%) 2 – 292,000 per year; 126,000 (43%) due to MRSA 3 Skin and Soft Tissue Infections – 12 million outpatient visits per year for SSTIs 4 – 76% of purulent infections in 11 ERs secondary to S aureus 5 78% of these due to MRSA with overall MRSA rate = 59% Invasive Infections 6 – Occurs in 94,000 persons/year – Mortality = 19,000 – 86% are healthcare-associated 1. Kuehnert, JID, 2006; 2. Klevens, CID, 2006; 3. Kuehnert, Emerg ID, 2005; 4. McCaig, Emerging ID, 2006; 5. Moran, NEJM, 2006; 6. Klevens, JAMA, 2007

Staphylococcal Colonization Among IDUs is Increasing in North America Nasal carriage screening in 2000 (N=299) and 2006 (N=301) among active IDUs in Vancouver Increase in S aureus colonization: 27.1%   39.5% Increase in MRSA colonization: 7.4%  18.6% MRSA PFGE changed from primarily USA-500 (100%) to USA-300 (75%) with increasing susceptibility to TMP/SMZ and TCN with USA-300 Trend toward increased recent antibiotic use (p=.056) and hospitalization (p=0.12) for MRSA vs. MSSA Al-Rawahi GN, J Clin Microbiol, 2008

S Aureus Carriage Among IDUs in Methadone and Heroin Maintenance Programs 2001: 70 MM and 94 HM patients in Basel, Switzerland Nasal carriage higher in MM (43%) than in HM (23%) patients – No difference in recent or remote hospitalization – MM subjects more likely to have used antibiotics in previous month (12% vs 4%), be HIV+ (20% vs 6%) and have no IDU (34% vs 0%) In multivariate analysis, enrolled in MM was the only significant (AOR 2.27) correlate of S aureus colonization No MRSA isolated, 1 but subsequent studies have demonstrated MRSA transmission between drug users 2 and introduction of new MRSA strains 3 1. Bassetti, Inf Control Hosp Epi, 2004; 2. Qi, J Clin Micro 2005; 3. Fleisch, Infection, 2005

Colonization with MRSA in Opioid Dependent Patients Case control study of 60 hospitalized opioid dependent (OD) and 60 non-drug users in Egypt – Subjects with any CDC risk for h-MRSA excluded (time extended to five years for health care facility) Colonization higher in drug vs. non-drug users (30% vs 10%) – Increased risk associated with duration of drug use and use of non-prescription antibiotics – 58% of active MRSA infections associated with colonization El-Sharif, Exp Biol Med, 2008

Rapid Spread of MRSA in the Netherlands Year No. Hospitals with MRSA PFT-16No. MRSA Isolates Wannet, J Clin Micro 2004

Hospitalization and S Aureus

Managing MRSA Colonization Colonization persists for years, despite treatment of infection Contact precautions and isolation of wounds recommended Controversy exists around universal screening, isolation and at eradication of the carrier state

Changing Epidemiology of Staphylococcal Infections Antibiotic Year Introduced Years to Report of Resistance Years until 25% rate in hospitals Years until 25% rate in community Penicillin Vancomycin195640??? Methicillin1961< (projected)

Summary IDUs exist on all continents and are more likely to be colonized with S aureus Morbidity and mortality related to S Aureus infections is greater among IDUs Colonization with S aureus, including MRSA, is associated with increased risk for infection Infection can be reduced with skin cleaning and sterile syringes MRSA prevalence is variable but growing in different regions of the world, thus requiring increased surveillance to guide clinical practice